WEBULL

3 UK Penny Stocks With Market Caps Over £100M To Consider

Simply Wall St · 10/01/2025 06:05

The United Kingdom's stock market has recently faced challenges, with the FTSE 100 index experiencing declines due to weaker trade data from China, reflecting broader global economic concerns. Despite these headwinds, investors continue to seek opportunities in smaller or newer companies that may offer untapped value. Penny stocks, though an older term, remain a relevant investment area for those looking to capitalize on companies with solid financial foundations and potential for growth.

Top 10 Penny Stocks In The United Kingdom

Name Share Price Market Cap Rewards & Risks
Foresight Group Holdings (LSE:FSG) £4.875 £545.79M ✅ 4 ⚠️ 0 View Analysis >
Warpaint London (AIM:W7L) £2.05 £165.61M ✅ 3 ⚠️ 2 View Analysis >
Helios Underwriting (AIM:HUW) £2.26 £161.68M ✅ 4 ⚠️ 3 View Analysis >
Ingenta (AIM:ING) £0.775 £11.7M ✅ 2 ⚠️ 2 View Analysis >
Integrated Diagnostics Holdings (LSE:IDHC) $0.545 $316.82M ✅ 4 ⚠️ 2 View Analysis >
Alumasc Group (AIM:ALU) £3.425 £123.16M ✅ 4 ⚠️ 1 View Analysis >
Begbies Traynor Group (AIM:BEG) £1.16 £184.68M ✅ 4 ⚠️ 3 View Analysis >
Croma Security Solutions Group (AIM:CSSG) £0.73 £10.05M ✅ 3 ⚠️ 4 View Analysis >
Braemar (LSE:BMS) £2.40 £73.12M ✅ 3 ⚠️ 3 View Analysis >
ME Group International (LSE:MEGP) £1.852 £699.54M ✅ 4 ⚠️ 1 View Analysis >

Click here to see the full list of 302 stocks from our UK Penny Stocks screener.

Let's explore several standout options from the results in the screener.

Diaceutics (AIM:DXRX)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Diaceutics PLC is a diagnostic commercialization company that offers data, data analytics, and implementation services to pharma and biotech companies, with a market cap of £140.48 million.

Operations: The company's revenue is derived entirely from its Medical Labs & Research segment, totaling £34.40 million.

Market Cap: £140.48M

Diaceutics PLC, with a market cap of £140.48 million, remains a compelling prospect in the penny stock arena due to its strategic focus on precision medicine commercialization. Despite being unprofitable and experiencing increased losses over the past five years, the company reported H1 2025 sales of £14.56 million, indicating growth from the previous year. Diaceutics is debt-free and maintains sufficient cash runway for over a year based on current free cash flow levels. Recent expansion of its PMx commercialization partnership underscores its potential for incremental service revenue and strengthens its role in precision medicine solutions.

AIM:DXRX Financial Position Analysis as at Oct 2025
AIM:DXRX Financial Position Analysis as at Oct 2025

Castings (LSE:CGS)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Castings P.L.C. is involved in iron casting and machining operations across various international markets, with a market cap of £113.86 million.

Operations: The company generates revenue from Foundry Operations amounting to £197.94 million and Machining Operations totaling £32.13 million.

Market Cap: £113.86M

Castings P.L.C., with a market cap of £113.86 million, presents a mixed picture for penny stock investors. The company is debt-free and maintains stable short-term assets (£100.1M) that cover both short and long-term liabilities, highlighting financial prudence. However, recent negative earnings growth (-75%) and declining profit margins (2.4% from 7.5% last year) are concerning despite high-quality past earnings and no shareholder dilution over the past year. The board's seasoned experience offers stability amid these challenges, while forecasts suggest potential earnings growth of 25.59% annually, albeit with current dividends not well covered by earnings or cash flows.

LSE:CGS Financial Position Analysis as at Oct 2025
LSE:CGS Financial Position Analysis as at Oct 2025

Hostelworld Group (LSE:HSW)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Hostelworld Group plc operates as an online travel agent specializing in the hostel market globally, with a market cap of £144.86 million.

Operations: The company generates revenue of €92.3 million from providing software and data processing services.

Market Cap: £144.86M

Hostelworld Group, with a market cap of £144.86 million, offers both opportunities and challenges for penny stock investors. The company is debt-free and has experienced significant earnings growth over the past five years. However, recent negative earnings growth and declining profit margins (8.3% from 16.1% last year) raise concerns despite high-quality earnings and stable weekly volatility (4%). The management team is experienced, but short-term liabilities (€20.4M) exceed short-term assets (€17.2M). Recent strategic moves include share buybacks, dividend increases, and active pursuit of acquisitions to bolster its position in the youth travel market.

LSE:HSW Debt to Equity History and Analysis as at Oct 2025
LSE:HSW Debt to Equity History and Analysis as at Oct 2025

Where To Now?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.